ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,498Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 35

$762K Total Retail Price of All Prescriptions

Rank: 12 out of 35

403 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 403 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 12,232 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 587 587 1 1
LEVOTHYROXINE SODIUM 578 578 2 3
POLYETHYLENE GLYCOL 3350 486 477 3 15
NAMENDA 419 419 4 12
DONEPEZIL HCL 379 379 5 7
POTASSIUM CHLORIDE 359 359 6 10
SIMVASTATIN 285 285 7 6
SERTRALINE HCL 278 278 8 18
WARFARIN SODIUM 264 261 9 8
OMEPRAZOLE 251 251 10 4
LISINOPRIL 235 219 11 5
AMLODIPINE BESYLATE 234 234 12 9
DIVALPROEX SODIUM 231 231 13 21
GABAPENTIN 226 199 14 14
METOPROLOL TARTRATE 203 203 15 11
METOPROLOL SUCCINATE 167 167 16 20
RISPERIDONE 166 166 17 27
MIRTAZAPINE 153 153 18 16
CYMBALTA 152 152 19 17
ALENDRONATE SODIUM 141 141 20 33
PAROXETINE HCL 128 113 21 88
HYDROCODONE-ACETAMINOPHEN 127 124 S3 22 2
TAMSULOSIN HCL 126 123 23 29
OLANZAPINE 118 118 24 40
PANTOPRAZOLE SODIUM 114 101 25 37
CARBIDOPA-LEVODOPA 112 112 26 48
DIGOXIN 108 108 27 49
ESCITALOPRAM OXALATE 106 106 28 30
TRAZODONE HCL 105 105 29 23
CITALOPRAM HBR 105 105 29 13
METFORMIN HCL 104 104 31 19
DIOVAN 104 104 31 66
ENOXAPARIN SODIUM 104 102 31 178
FAMOTIDINE 101 101 34 35
LOSARTAN POTASSIUM 94 94 35 38
ATENOLOL 92 92 36 31
LANTUS 91 91 37 26
TRAMADOL HCL 91 91 37 24
ALLOPURINOL 86 86 39 47
LIDOCAINE 85 85 40 222
QUETIAPINE FUMARATE 83 83 41 39
PRAVASTATIN SODIUM 80 70 42 32
ATORVASTATIN CALCIUM 79 79 43 28
PREDNISONE 77 77 44 36
LEVETIRACETAM 77 77 44 53
EXELON 77 77 44 59
CEPHALEXIN 75 72 47 50
CLOPIDOGREL 74 67 48 34
CARVEDILOL 73 61 49 25
IPRATROPIUM-ALBUTEROL 67 65 50 64
AMMONIUM LACTATE 63 56 51 286
ISOSORBIDE MONONITRATE ER 59 59 52 43
NOVOLOG 58 58 53 42
NYSTOP 55 55 54 112
ADVAIR DISKUS 52 42 55 46
ALBUTEROL SULFATE 51 49 56 58
LEVOFLOXACIN 51 50 56 75
RIVASTIGMINE 51 51 56 199
CIPROFLOXACIN HCL 51 48 56 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.